Atlas Corp. (NYSE: ATCO) rose 21.4% to $14.06 in pre-market trading after the company said it received a non-binding proposal from Poseidon Acquisition Corp. to acquire all outstanding common shares of Atlas for $14.45 per share.
RBC Capital Markets views Galapagos' NV (NASDAQ: GLPG) Q1 Jyseleca revenues in line as the story focuses on whether new leadership can unlock value from GLPG's ample balance sheet.
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news flow continued to dominate proceedings, and the week also witnessed presentations at conferences and a couple of initial public offerings.
US stocks turned lower in another volatile trading session on Thursday despite stronger-than-expected GDP data. The country’s economy grew 6.9% on quarter during the last three months of previous year, up from 2.3% expansion in the prior quarter and also above market estimates of 5.5%.
The Dow Jones extended gains, surging by more than 500 points. The country’s economy grew 6.9% on quarter during the last three months of previous year, up from 2.3% expansion in the prior quarter and also above market estimates of 5.5%.